Wolters Kluwer NV (XTER:WOSB) Research & Development: €0 Mil (TTM As of Dec. 2025)


XTER:WOSB Wolters Kluwer NV XTER:WOSB
76 GF Score
Price €57.66
GF Value €156.99
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Wolters Kluwer NV Research & Development?

Wolters Kluwer NV XTER:WOSB +1.84% 76 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates XTER:WOSB with a GF Score™ of 76/100 and a GF Value™ of €156.99 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Wolters Kluwer NV's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Wolters Kluwer NV  (XTER:WOSB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Wolters Kluwer NV Research & Development Related Terms

Wolters Kluwer NV Research & Development Historical Data

* Premium members only.

The historical data trend for Wolters Kluwer NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wolters Kluwer NV Research & Development Chart

Wolters Kluwer NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 466.00 541.00 591.00 688.00 724.00

Wolters Kluwer NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTER:WOSB
76GF Score
Wolters Kluwer NV XTER:WOSB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wolters Kluwer NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Wolters Kluwer NV (XTER:WOSB) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Wolters Kluwer NV and its competitors.
Is Wolters Kluwer NV's Research & Development too high?
Wolters Kluwer NV's current Research & Development is €0 Mil. Overall, Wolters Kluwer NV has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wolters Kluwer NV's Research & Development compare to CTAS and CPRT?
Wolters Kluwer NV's Research & Development of €0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Wolters Kluwer NV and its competitors. Wolters Kluwer NV's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wolters Kluwer NV stock overvalued right now?
Based on GuruFocus' analysis, Wolters Kluwer NV (XTER:WOSB) is currently considered Significantly Undervalued. The stock's GF Value™ is €156.99, compared to a current price of €57.66 — trading 63.3% below its estimated fair value. The current Research & Development is €0 Mil. Wolters Kluwer NV's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Wolters Kluwer NV (XTER:WOSB), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wolters Kluwer NV (XTER:WOSB) Overvalued in 2026?

Based on GuruFocus' analysis, Wolters Kluwer NV stock appears to be undervalued. The current stock price of €57.66 is trading 63.3% below its estimated GF Value™ of €156.99. GuruFocus considers Wolters Kluwer NV to be Significantly Undervalued.

Key valuation signals for XTER:WOSB:

  • Research & Development: €0 Mil
  • GF Value™: €156.99 vs. price of €57.66 (63.3% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XTER:WOSB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wolters Kluwer NV Business Description

Address Zuidpoolsingel 2, P.O. Box 1030, Alphen aan den Rijn, ZH, NLD, 2400
Wolters Kluwer is a global provider of professional information, software solutions, and services in health; tax and accounting; environmental, social, and governance; finance; compliance; and legal. More than 60% of revenue is generated in North America and around 30% is from Europe.
76GF Score

Get the complete analysis for XTER:WOSB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€57.66
Price
€156.99
GF Value